|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project. Thromb Haemost. 2017 Oct 5;117(10):1848-1858. doi: 10.1160/TH17-07-0478. Epub 2017 Aug 11. PubMed PMID: 28799620.
AÑO: 2017; IF: 4.952
|
28799620
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA(2)DS(2)-VASc Scores. J Am Heart Assoc. 2017 Jul 20;6(7). pii: e006490. doi: 10.1161/JAHA.117.006490. PubMed PMID: 28729407; PubMed Central PMCID: PMC5586327.
AÑO: 2017; IF: 4.45
|
|
Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Lip GYH. Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Expert Opin Drug Saf. 2017 Sep;16(9):1051-1062. doi: 10.1080/14740338.2017.1351542. Epub 2017 Jul 12. Review. PubMed PMID: 28678553.
AÑO: 2017; IF: 3.156
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Vicente V, Romiti GF, Romanazzi I, Proietti M, Valdés M, Marín F, Lip GYH. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. Int J Cardiol. 2018 Mar 1;254:125-131. doi: 10.1016/j.ijcard.2017.11.087. Epub 2017 Dec 14. PubMed PMID: 29248163.
AÑO: 2018; IF: 3.471
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Marín F, Lip GYH. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. Clin Ther. 2018 Jan;40(1):114-122. doi: 10.1016/j.clinthera.2017.11.014. Epub 2017 Dec 21. PubMed PMID: 29275065.
AÑO: 2018; IF: 2.935
|